共 50 条
- [31] Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trialLANCET ONCOLOGY, 2022, 23 (12): : 1571 - 1582Del Mastro, LuciaPoggio, FrancescaBlondeaux, EvaDe Placido, SabinoGiuliano, MarioForestieri, ValeriaDe laurentiis, MichelinoGravina, AdrianoBisagni, GiancarloRimanti, AnitaTurletti, AnnaNistico, CeciliaVaccaro, AngelaCognetti, FrancescoFabi, AlessandraGasparro, SimonaGarrone, OrnellaAlicicco, Maria GraziaUrracci, YleniaMansutti, MauroPoletti, PaolaCorreale, PierpaoloBighin, ClaudiaPuglisi, FabioMontemurro, FilippoColantuoni, GiuseppeLambertini, MatteoBoni, Luca
- [32] Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Primary Results of a Randomized, 2 x 2 Factorial, Placebo-Controlled, Double-Blind Clinical TrialCIRCULATION, 2015, 132 (23) : 2274 - 2274Gulati, GeetaHeck, Siri L.Hoffmann, PavelRee, Anne H.Schulz-Menger, Jeanettevon Knobelsdorff-Brenkenhoff, FlorianSteine, KjetilBratland, AseGravdehaug, BeritRosjo, HelgeGeisler, JuergenOmland, Torbjorn
- [33] Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 x 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprololEUROPEAN HEART JOURNAL, 2016, 37 (21) : 1671 - 1680Gulati, GeetaHeck, Siri LagethonRee, Anne HansenHoffmann, PavelSchulz-Menger, JeanetteFagerland, Morten W.Gravdehaug, Beritvon Knobelsdorff-Brenkenhoff, FlorianBratland, AseStoras, Tryggve H.Hagve, Tor-ArneRosjo, HelgeSteine, KjetilGeisler, JurgenOmland, Torbjorn
- [34] Phase III randomized, multicenter trial comparing high-dose IFN-a2b with temozolomide plus cisplatin as adjuvant therapy for resected mucosal melanomaJOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)Lian, BinCui, ChuanliangSong, XinZhang, XiaoshiWu, DiSi, LuChi, ZhihongSheng, XinanKong, YanMao, Li LiZhou, LiWang, XuanTang, BixiaYan, XieqiaoLi, SimingLi, DanDai, JieBai, XueLi, CaiLiGuo, Jun
- [35] Phase II Randomized Trial Comparing High-Dose IFN-α2b with Temozolomide Plus Cisplatin as Systemic Adjuvant Therapy for Resected Mucosal MelanomaCLINICAL CANCER RESEARCH, 2013, 19 (16) : 4488 - 4498Lian, BinSi, LuCui, ChuanliangChi, ZhihongSheng, XinanMao, LiliLi, SimingKong, YanTang, BixiaGuo, Jun
- [36] Quality of life, patient satisfaction, and cardiovascular outcomes of the randomised 2 x 3 factorial Copenhagen insulin and Metformin therapy (CIMT) trial-A detailed statistical analysis planCONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2023, 33Olsen, Markus HarboeAlmdal, Thomas P.Madsbad, StenOvesen, ChristianGluud, ChristianSneppen, Simone B.Breum, LeifHedetoft, ChristofferKrarup, ThureLundby-Christensen, LouiseMathiesen, Elisabeth R.Roder, Michael E.Vestergaard, HenrikWiinberg, NielsJakobsen, Janus C.
- [37] Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study)Discover Oncology, 14Wan-Soo YoonJong Hee ChangJeong Hoon KimYu Jung KimTae-Young JungHeon YooSe-Hyuk KimYoung-Cho KoDo-Hyun NamTae Min KimSe Hoon KimSung-Hae ParkYoun Soo LeeHyeon Woo YimYong-Kil HongSeung Ho Yang
- [38] Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study)DISCOVER ONCOLOGY, 2023, 14 (01)Yoon, Wan-SooChang, Jong HeeKim, Jeong HoonKim, Yu JungJung, Tae-YoungYoo, HeonKim, Se-HyukKo, Young-ChoNam, Do-HyunKim, Tae MinKim, Se HoonPark, Sung-HaeLee, Youn SooYim, Hyeon WooHong, Yong-KilYang, Seung Ho
- [39] PANTHER: Prospective randomized phase III trial of tailored and dose-dense versus standard tri-weekly adjuvant chemotherapy for high-risk breast cancer in the modern era of endocrine and anti-HER2 therapy.JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)Bergh, Jonas C. S.Foukakis, Theodorosvon Minckwitz, GunterBengtsson, Nils-OlofWallberg, BirgittaFornander, TommyMlineritsch, BrigitteSchmatloch, SabineSinger, Christian F.Steger, Guenther G.Karlsson, EvaCarlsson, LenaLoibl, SibylleUntch, MichaelHellstrom, MatsJohansson, HemmingMalmstrom, PerGnant, MichaelGreil, RichardMoebus, Volker
- [40] SURVIVAL AND TOXICITY UPDATE OF THE PHASE 2 TRIAL OF BEVACIZUMAB (BV) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) FOLLOWED BY BV, TMZ, AND IRINOTECAN (CPT-11) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) PATIENTSNEURO-ONCOLOGY, 2010, 12 : 77 - 77Desjardins, AnnickReardon, David A.Peters, Katherine B.Herndon, James E., IIKirkpatrick, John P.Friedman, Henry S.Vredenburgh, James J.